Alerts, recalls and safety information
This safety information is provided by the Medicines and Healthcare products Regulatory Agency (MHRA), the UK regulator for medicines and medical devices. These alerts may cover medicines, vaccines or medical devices, and can include new safety warnings, prescribing advice, product recalls or field safety notices. They are issued to protect patients and to help healthcare professionals provide safe, effective care.
Patient.info republishes these updates so that both professionals and the public can access the latest official safety communications in one place.
More Information
- Class 4 Medicines Defect Notification: Fexofenadine Hydrochloride 120mg film-coated tablets, Chanelle Medical Unlimited Company, EL(25)A/41
- Class 4 Medicines Defect Notification: Hikma Farmacêutica, Gemcitabine 2g/52.6ml concentrate for solution for infusion, EL(25)A/43
- Class 4 Medicines Defect Notification: Ipca Laboratories UK Limited, Various Products, EL(25)A/42
- Class 4 Medicines Defect Notification: Levetiracetam Accord 100mg/ml oral solution, Accord Healthcare Limited, UK, EL(25)A/40
- Field Safety Notices: 1 to 5 September 2025
- Field Safety Notices: 11 to 15 August 2025
- Field Safety Notices: 15 to 19 September 2025
- Field Safety Notices: 18 to 22 August 2025
- Field Safety Notices: 22 to 26 September 2025
- Field Safety Notices: 25 to 29 August 2025
- Field Safety Notices: 8 to 12 September 2025
- MHRA Safety Roundup: August 2025
- MHRA Safety Roundup: September 2025
- Paracetamol and pregnancy - reminder that taking paracetamol during pregnancy remains safe
- Profemur Cobalt Chrome Modular Neck Hip Replacements: Higher than anticipated risk of revision surgery, metal-wear effects and component fracture (DSI/2025/005)